Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

62 results about "Polyphosphate kinase" patented technology

In enzymology, a polyphosphate kinase (EC 2.7.4.1), or polyphosphate polymerase, is an enzyme that catalyzes the formation of polyphosphate from ATP, with chain lengths of up to a thousand or more orthophosphate moieties. ATP + (phosphate)ₙ ⇌ ADP + (phosphate)ₙ₊₁ Thus, the two substrates of this enzyme are ATP and polyphosphate [(phosphate)n], whereas its two products are ADP and polyphosphate extended by one phosphate moiety [(phosphate)n+1].

Inositol polyphosphate kinase genes and uses thereof

This invention relates to newly identified polynucleotides and polypeptides in the phytic acid biosynthetic pathway, variants and derivatives of same; methods for making the polynucleotides, polypeptides, variants, derivatives and antagonists. In particular the invention relates to polynucleotides and polypeptides of the inositol polyphosphate kinase gene family. In particular this invention relates to using the newly identified polynucleotides and polypeptides to modulate the phytic acid biosynthesis in such a way as to decrease phytate and / or increase non-phytate phosphorous, especially in corn or soy animal feedstuffs.
Owner:PIONEER HI BRED INT INC +1

Method for preparing sialyllactose

InactiveCN110396532ASimple ingredientsClear ingredientsFermentationSialyltransferaseCMP-Sialic Acid Synthetase
The invention discloses a method for preparing sialyllactose, and relates to the technical field of preparation of sialyllactose. The method for preparing sialyllactose disclosed by the invention comprises the steps of adding kinase to a reaction system containing a substrate, and performing an enzyme catalysis reaction to prepare the sialyllactose, wherein the kinase comprises CMP kinase, polyphosphate sialic acid synthase and sialytransferase; and the substrate comprises CMP, polyphosphate, sialic acid and lactose. The method adopts various kinase namely the CMP kinase, the polyphosphate kinase, the CMP-sialic acid synthetase and sialytransferase to catalyze the corresponding substrate to prepare the sialyllactose. The method has the characteristics of being high in yield, low in cost, short in cycle and the like.
Owner:HEFEI INSTITUTES OF PHYSICAL SCIENCE - CHINESE ACAD OF SCI +1

Recombinant plasmid for eliminating industrial wastewater mercury pollution, construction method, recombinant engineering bacterium and application

The invention discloses a recombinant plasmid for eliminating industrial wastewater mercury pollution, a construction method, a recombinant engineering bacterium and an application. The recombinant plasmid is established by inserting tobacco chloroplast rrn16 gene strong promoter, ribosome binding site conserved sequence of 5'UTR sequence of escherichia coli T7 phage gene 10, 3'-end non-coding area of tobacco chloroplast rps16 gene, enterobacter aerogenes polyphosphate kinase gene ppk and pseudomonas K-62 strain on the basis of plasmid pET28a and by eliminating mer operon of merA and merG. Organic mercury and inorganic mercury in wastewater are transferred into bacterial cells through merT-merP, the organic mercury is degraded into divalent mercury through merB1 and merB2, the divalent mercury is chelated into the cells through ppk, the toxicity of mercury to the bacteria cells is reduced, mercury in the wastewater is accumulated inside the bacterial cells, and mercury pollution in the waster is eliminated through collecting the recombinant engineering bacteria.
Owner:舒海燕 +1

Method for synthetizing L-carnosine by one-step method and truncated L-carnosine synthetase

The invention discloses a method for synthetizing L-carnosine by a one-step method and truncated L-carnosine synthetase. According to the method, beta-alanine, L-histidine, ATP and polyphosphate are used as raw materials, MgCl2 is used as an activator, L-carnosine synthetase and polyphosphate kinase are added, and through an enzymatic reaction under the condition of pH being 6.5-8.5 and the temperature being 30-45 DEG C, the carnosine is coupled, catalyzed and synthetized. According to the method disclosed by the invention, escherichia coli is used for respectively expressing the truncated L-carnosine synthetase (of which the amino acid sequence is as shown in SEQID No.3) and the polyphosphate kinase, through purification, mixing is performed, a dual-enzyme coupling system is formed, and the L-carnosine synthetase in truncated expression can catalyze the L-carnosine synthetized from beta-alanine and L-histidine; besides, accompanied with ATP dephosphorylation, ADP is formed, the polyphosphate kinase catalyzes polyphosphate transphosphorylation groups, and ATP is formed for the ADP, so that circulation and regeneration of the ATP can be realized; and through the dual-enzyme couplingsystem, a reaction is performed under the appropriate reaction condition, so that carnosine is obtained. The method disclosed by the invention has the advantages that the raw materials are low in cost, the enzymatic conversion time is short, the operation is simple and convenient, and the production cost is low.
Owner:苏州百因诺生物科技有限公司

Method for preparing uridylic acid by enzyme method

The invention, which belongs to the technical field of biological pharmacy and biochemical engineering, discloses an enzyme composition for uridylic acid production and a method for preparing uridylicacid by an enzyme method. The enzyme composition is prepared by cytidine deaminase, polyphosphate kinase and uridine-cytidine kinase. The three enzymes are reasonably combined to efficiently catalyzeand prepare uridylic acid. The enzyme composition disclosed by the invention can be recycled and is low in cost; and energy-saving and environment-friendly effects are realized. According to the invention, the cytidine is used as a substrate and the enzyme composition for uridylic acid production is added, so that the uridylic acid is prepared with low cost and high safety and reliability; the cost of the existing route is reduced; and the large-scale production is realized. The application of uridylic acid in fields of biocatalysis and medicines is guaranteed.
Owner:杭州唯泰生物药业有限公司 +1

Enzymatic synthesis method of nicotinamide mononucleotide

The invention discloses an enzymatic synthesis method of nicotinamide mononucleotide. The enzymatic synthesis method comprises the following steps: S1, taking ribose-5-phosphate, cytidine monophosphate, polyphosphate and nicotinamide as raw materials, and generating nicotinamide mononucleotide under the catalytic action of ribose phosphate pyrophosphorylase, polyphosphate kinase and nicotinamide ribose phosphate transferase. The applicant uses polyphosphate kinase to catalyze cytidine monophosphate to cyclically obtain cytidine triphosphate by using a phosphate group provided by the polyphosphate, and the cytidine triphosphate is used as a pyrophosphoric acid donor of the ribose phosphate pyrophosphorylase to promote the enzymatic reaction of the ribose-5 phosphate and the nicotinamide, thereby avoiding the use of expensive ATP (adenosine triphosphate). Besides, the cytidine monophosphate and the cytidine triphosphate in the enzymatic reaction process provided by the invention are almost insoluble in water under an acidic condition, so that impurities in the product can be quickly, simply and conveniently removed by directly adjusting the pH value after the reaction is finished, the purification process is simplified, and the separation and purification difficulty is reduced.
Owner:深圳希吉亚生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products